Skip to main navigation
Taysha Gene Therapies Logo
  • About Us
    • Our Story
    • Our Mission & Values
    • Our Team
      • Leadership
      • Board of Directors
      • Scientific Advisory Board
  • Our Science
    • What is Gene Therapy
    • The Taysha Strategy
  • Pipeline
    • Other Programs
    • TSHA-102 in Rett Syndrome
  • Healthcare Professionals
    • Clinical Trials
    • Scientific Posters & Publications
    • Expanded Access Policy
  • Patients & Caregivers
    • Our Guiding Principles
    • Community Support and Resources
    • Patient Affairs
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
    • Shareholder Resources
      • FAQs
      • Contact IR
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
  • Careers
    • Heart of Taysha
    • Open Positions
  • Contact

    Event Details

    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports
      • Quarterly Reports
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
    • Shareholder Resources
      • FAQs
      • Contact IR
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
    • Analyst Coverage
    Back

    Taysha Gene Therapies Full-Year 2025 Financial Results Conference Call

    Mar 19, 2026 8:30 AM EDT

    Listen to webcast
    • Print Page
    • RSS Feeds
    • Email Alerts
    • Contact IR
    • About Us
      • Our Story
      • Our Mission & Values
      • Our Team
        • Leadership
        • Board of Directors
        • Scientific Advisory Board
    • Our Science
      • What is Gene Therapy
      • The Taysha Strategy
    • Pipeline
      • Other Programs
      • TSHA-102 in Rett Syndrome
    • Healthcare Professionals
      • Clinical Trials
      • Scientific Posters & Publications
      • Expanded Access Policy
    • Patients & Caregivers
      • Our Guiding Principles
      • Community Support and Resources
      • Patient Affairs
    • Investors
      • Overview
      • Press Releases
      • Events & Presentations
      • Financials & Filings
        • SEC Filings
        • Annual Reports
        • Quarterly Reports
      • Corporate Governance
        • Documents & Charters
        • Management Team
        • Board of Directors
      • Shareholder Resources
        • FAQs
        • Contact IR
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
      • Analyst Coverage
    • Careers
      • Heart of Taysha
      • Open Positions
    • Contact

    Corporate Headquarters
    3000 Pegasus Park Drive, Suite 1430
    Dallas, Texas 75247

    Laboratory Facility
    Morrisville, NC 27560

    Copyright 2026 Taysha Gene Therapies | Privacy Notice Terms of Service
    Scroll to top